GHCM
ALNA

Glen Harbor Capital Management’s Allena Pharmaceuticals ALNA Stock Holding History

Glen Harbor Capital Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-464
Closed -$2K – 1356
2019
Q2 		$2K Hold
464
– – ﹤0.01% 1322
2019
Q1 		$3K Sell
464
-16
-3% -$116 ﹤0.01% 1300
2018
Q4 		$3K Buy
+480
New +$4.14K ﹤0.01% 1278

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Glen Harbor Capital Management's ALNA Position: Q3 2019 in Review

Glen Harbor Capital Management sold out of Allena Pharmaceuticals (ALNA) in Q3 2019, closing a stake of 464 shares — an estimated $2K sold.

Glen Harbor Capital Management first reported a position in ALNA in Q4 2018 and held it in 3 quarters. The position peaked at $3K in Q1 2019. 35 funds tracked by Wall St. Rank hold ALNA as of Q3 2019.

  • Glen Harbor Capital Management reported no remaining Allena Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Glen Harbor Capital Management sold 464 Allena Pharmaceuticals shares in Q3 2019, an estimated $2K.
  • Glen Harbor Capital Management first reported a position in Allena Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Glen Harbor Capital Management's Allena Pharmaceuticals position peaked at $3K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.